A detailed history of Atlas Wealth LLC transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Wealth LLC holds 26,620 shares of PVCT stock, worth $2,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,620
Previous 26,620 -0.0%
Holding current value
$2,662
Previous $4.87 Million 30.35%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.04 - $0.18 $1,064 - $4,791
26,620 New
26,620 $2.88 Million

Others Institutions Holding PVCT

About PROVECTUS BIOPHARMACEUTICALS, INC.


  • Ticker PVCT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 419,496,992
  • Market Cap $41.9M
  • Description
  • Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...
More about PVCT
Track This Portfolio

Track Atlas Wealth LLC Portfolio

Follow Atlas Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Wealth LLC with notifications on news.